サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786541

PET放射性トレーサー市場：世界の産業分析、規模、シェア、成長、動向、予測、2025年～2032年

PET Radioactive Tracers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 350 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
PET放射性トレーサー市場：世界の産業分析、規模、シェア、成長、動向、予測、2025年～2032年
出版日: 2025年08月01日
発行: Persistence Market Research
ページ情報: 英文 350 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、PET放射性トレーサーの世界市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • PET放射性トレーサー市場規模（2025年）：10億6,980万米ドル
  • 市場予測値（2032年）：17億670万
  • 世界市場成長率（CAGR 2025年～2032年）：6.9%

PET放射性トレーサー市場：調査範囲

陽電子放射断層撮影法（PET）放射性トレーサーは、核医学イメージングにおける重要なコンポーネントであり、分子レベルでの生理学的プロセスのリアルタイム可視化を可能にします。これらのトレーサーは、主にフッ素-18、炭素-11、ガリウム-68などの同位体で標識されており、腫瘍学、心臓病学、神経学などの用途に広く使用されています。PET放射性トレーサー市場は、病院、画像診断センター、研究機関にサービスを提供し、正確な診断、病気の病期分類、治療モニタリング、薬剤開発をサポートしています。市場成長の原動力は、がんや神経疾患の有病率の増加、高度な画像診断モダリティに対する需要の高まり、臨床および前臨床におけるPET画像診断の利用拡大です。

市場促進要因：

世界のPET放射性トレーサー市場は、がんやアルツハイマー病など、精密かつ早期診断イメージングを必要とする慢性疾患の負担増など、いくつかの要因によって推進されています。PET/CTやPET/MRIシステムのようなハイブリッドイメージング技術の採用が増加していることも、トレーサー需要をさらに刺激しています。特定の受容体や代謝経路を標的とする放射性医薬品を含むトレーサー開発における継続的な技術革新は、診断精度を高め、臨床的有用性を拡大します。さらに、分子イメージング研究に対する政府の資金援助、先進国市場における有利な償還シナリオ、PETの臨床的利点に関する臨床医の意識の高まりが、市場の堅調な成長に寄与しています。

市場抑制要因：

有望な見通しにもかかわらず、PET放射性トレーサー市場はいくつかの制約に直面しています。これには、PETイメージング手技のコストが高いこと、トレーサーの半減期が短いことなどが含まれ、サイクロトロン施設への近接性や信頼性の高い放射性医薬品サプライチェーンが必要となります。新しいトレーサーの承認と製造における規制上のハードル、放射性物質の取り扱いと輸送のための複雑なロジスティクスが、運用上の課題を生み出しています。さらに、低資源環境ではPETイメージングへのアクセスが限られており、熟練した核医学専門家が不足しているため、特に新興国では普及の妨げとなっています。

市場機会：

PET放射性トレーサー市場は、放射性トレーサーの市場開拓と放射性医薬品製造の自動化における技術進歩に後押しされ、大きな成長機会をもたらしています。免疫腫瘍学、心血管イメージング、神経変性疾患モニタリングのための新規トレーサーの出現は、臨床応用を拡大し、精密医療アプローチをサポートします。発展途上国におけるPETイメージング施設の設立が増加しており、放射性医薬品インフラを改善するための官民パートナーシップと相まって、未開拓の可能性を提供しています。さらに、標的治療用のコンパニオン診断薬を開発するための製薬企業と画像ソリューションプロバイダーとのコラボレーションは、市場の将来性を強化しています。

本レポートで扱う主な質問

  • PET放射性トレーサー市場の世界的成長を促進する主な要因は何か？
  • イメージングセンター全体でトレーサーの利用を促進している同位体や臨床用途は何か？
  • 規制の枠組みや技術革新は競合情勢をどのように形成しているか？
  • PET放射性トレーサー市場の主要企業は誰で、どのような戦略を採用しているのか？
  • トレーサー開発と採用に関する新たな動向と今後の方向性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • イノベーション/開発動向

第4章 重要成功要因

  • PETスキャナ導入シナリオ
  • 国別PETスキャン件数
  • 疾病疫学
  • 製品の採用/使用状況分析
  • 規制承認の経路
  • 償還シナリオ
  • 技術の進歩
  • 適正製造規範（cGMP）
  • バリューチェーン分析
  • 品質基準/認定
  • PESTEL分析
  • ポーター分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • 2021年の市場シナリオ
  • COVID-19と影響分析
    • 製品別
    • 用途別
    • エンドユーザー別
    • 地域別

第7章 世界市場の需要分析

  • 市場金額の実績分析、2019年～2024年
  • 現在および将来の市場金額予測、2025年～2032年
    • 前年比成長動向分析
    • 絶対的収益機会分析

第8章 製品別世界市場分析

  • イントロダクション/主な調査結果
  • 製品別市場規模の推移分析、2019年～2024年
  • 製品別の現在および将来の市場規模分析と予測、2025年～2032年
    • F-18
      • フロルベタピル
      • フロルベタベン
      • フルテメタモール
      • フルデオキシグルコース
      • フッ化ナトリウム
      • その他
    • C-11
      • コリン
      • メチオニン
      • その他
    • Ga-68
      • DOTA-TOC
      • ドタテ
      • ドタノック
      • その他
    • O-15
    • N-13
    • Cu-64
  • エンドユーザー別市場の魅力分析

第9章 用途別世界市場分析

  • イントロダクション/主な調査結果
  • 用途別市場規模の実績分析、2019年～2024年
  • 用途別の現在および将来の市場規模分析と予測、2025年～2032年
    • 神経疾患
      • アルツハイマー病
      • 痴呆
      • その他
    • がんの診断と予後
      • 固形腫瘍
      • 血液腫瘍
    • 心臓機能障害
      • 心筋梗塞
      • その他
    • 感染症の診断
    • その他
  • エンドユーザー別市場の魅力分析

第10章 エンドユーザー別世界市場分析

  • イントロダクション/主な調査結果
  • エンドユーザー別市場規模の歴史的分析、2019年～2024年
  • エンドユーザー別の現在および将来の市場規模分析と予測、2025年～2032年
    • 病院
    • 専門診断センター
    • がん研究センター
    • 学術研究機関
  • エンドユーザー別市場の魅力分析

第11章 地域別世界市場分析

  • イントロダクション
  • 地域別市場規模の歴史的分析、2019年～2024年
  • 地域別の現在および将来の市場規模分析と予測、2025年～2032年
    • 北米
    • ラテンアメリカ
    • 東アジア
    • 南アジア・太平洋
    • 西欧
    • 東欧
    • 中央アジア
    • ロシアとベラルーシ
    • バルカン半島およびバルト諸国
    • 中東・アフリカ
  • 地域別市場の魅力分析

第12章 北米市場分析

第13章 ラテンアメリカ市場分析

第14章 東アジア市場分析

第15章 南アジア・太平洋地域の市場分析

第16章 西欧市場分析

第17章 東欧市場分析

第18章 中央アジア市場分析

第19章 ロシアとベラルーシの市場分析

第20章 バルカン半島およびバルト諸国のアジア市場分析

第21章 中東・アフリカ（MEA）市場分析

第22章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第23章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Eli Lilly and Company
    • Blue Earth Diagnostics
    • Lantheus
    • Siemens Healthcare Private Limited
    • GE Healthcare
    • Advanced Accelerator Applications（Novartis）
    • University of Lowa HealthCare
    • Telix Pharmaceuticals Limited
    • Jubilant Radiopharma
    • TRASIS
    • RadioMedix Inc.
    • IBA Radiopharma Solutions
    • Piramal Imaging（Life Molecular Imaging）
    • Cardinal Health
    • DuchemBio, Co., Ltd

第24章 前提と使用される頭字語

第25章 調査手法

目次
Product Code: PMRREP33446

Persistence Market Research has recently released a comprehensive report on the worldwide market for PET radioactive tracers. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • PET Radioactive Tracers Market Size (2025E): USD 1,069.8 Million
  • Projected Market Value (2032F): USD 1,706.7 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.9%

PET Radioactive Tracers Market - Report Scope:

Positron Emission Tomography (PET) radioactive tracers are critical components in nuclear medicine imaging, enabling real-time visualization of physiological processes at the molecular level. These tracers, primarily labeled with isotopes such as Fluorine-18, Carbon-11, and Gallium-68, are widely used for oncology, cardiology, and neurology applications. The PET radioactive tracers market serves hospitals, diagnostic imaging centers, and research institutions, supporting accurate diagnosis, disease staging, therapy monitoring, and drug development. Market growth is driven by the increasing prevalence of cancer and neurological disorders, rising demand for advanced imaging modalities, and the expanding use of PET imaging in clinical and preclinical settings.

Market Growth Drivers:

The global PET radioactive tracers market is propelled by several factors, including the growing burden of chronic diseases such as cancer and Alzheimer's disease, which require precise and early diagnostic imaging. The rising adoption of hybrid imaging technologies like PET/CT and PET/MRI systems further stimulates tracer demand. Continued innovation in tracer development, including radiopharmaceuticals targeting specific receptors and metabolic pathways, enhances diagnostic accuracy and broadens clinical utility. Moreover, government funding for molecular imaging research, favorable reimbursement scenarios in developed regions, and increasing awareness among clinicians regarding PET's clinical benefits contribute to robust market growth.

Market Restraints:

Despite a promising outlook, the PET radioactive tracers market faces several constraints. These include the high cost of PET imaging procedures and the short half-life of tracers, which necessitates proximity to cyclotron facilities and reliable radiopharmaceutical supply chains. Regulatory hurdles in the approval and production of new tracers, along with complex logistics for handling and transporting radioactive materials, create operational challenges. Additionally, limited access to PET imaging in low-resource settings and a shortage of skilled nuclear medicine professionals hinder widespread adoption, particularly in emerging economies.

Market Opportunities:

The PET radioactive tracers market presents significant growth opportunities fueled by technological advances in radiotracer development and automation in radiopharmacy. The emergence of novel tracers for immuno-oncology, cardiovascular imaging, and neurodegenerative disease monitoring expands clinical applications and supports precision medicine approaches. The increasing establishment of PET imaging facilities in developing countries, coupled with public-private partnerships to improve radiopharmaceutical infrastructure, offers untapped potential. Furthermore, collaborations between pharmaceutical companies and imaging solution providers to develop companion diagnostics for targeted therapies strengthen the market's future prospects.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the PET radioactive tracers market globally?
  • Which isotopes and clinical applications are driving tracer utilization across imaging centers?
  • How are regulatory frameworks and technological innovations shaping the competitive landscape?
  • Who are the key players in the PET radioactive tracers market, and what strategies are they adopting?
  • What are the emerging trends and future directions for tracer development and adoption?

Competitive Intelligence and Business Strategy:

These companies invest in R\&D to develop new fluorinated tracers, streamline synthesis procedures, and ensure regulatory compliance. Partnerships with academic institutions, pharmaceutical firms, and cyclotron manufacturers enhance tracer availability and support clinical research. Moreover, emphasis on automation, GMP-compliant production facilities, and distribution network expansion enables key players to maintain competitive advantage and meet the growing global demand.

Key Companies Profiled:

  • Eli Lilly and Company
  • Blue Earth Diagnostics
  • Lantheus
  • Siemens Healthcare Private Limited
  • GE Healthcare
  • Advanced Accelerator Applications (Novartis)
  • University of Lowa HealthCare
  • Telix Pharmaceuticals Limited
  • Jubilant Radiopharma
  • TRASIS
  • RadioMedix Inc.
  • IBA Radiopharma Solutions
  • Piramal Imaging (Life Molecular Imaging)
  • Cardinal Health
  • DuchemBio, Co. Ltd.

PET Radioactive Tracers Market Research Segmentation:

Product:

  • F-18
    • * Florbetapir
    • * Florbetaben
    • * Flutemetamol
    • * Fludeoxyglucose
    • * Sodium Fluoride
    • * Others
  • C-11
    • * Choline
    • * Methionine
    • * Others
  • Ga-68
    • * DOTA-TOC
    • * DOTATATE
    • * DOTANOC
    • * Others
  • O-15
  • N-13
  • Cu-64

Application:

  • Neurological Disorders
    • * Alzheimer's Disease
    • * Dementia
    • * Others
  • Cancer Diagnosis & Prognosis
    • * Solid Tumors
    • * Hematology Tumors
  • Cardiac Dysfunctions
    • * Myocardial Infarction
    • * Others
  • Infectious Disease Diagnosis
  • Others

End User:

  • Hospitals
  • Speciality Diagnostic Centers
  • Cancer Research Centers
  • Academic & Research Institutes

Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Innovation / Development Trends

4. Key Success Factors

  • 4.1. PET Scanner Installed Base Scenario
  • 4.2. Number of PET Scans, By Country
  • 4.3. Disease Epidemiology
  • 4.4. Product Adoption/Usage Analysis
  • 4.5. Regulatory Approval Pathway
  • 4.6. Reimbursement Scenario
  • 4.7. Technology Advancements
  • 4.8. Good Manufacturing Practice (cGMP)
  • 4.9. Value Chain Analysis
  • 4.10. Quality Standards/Accreditations
  • 4.11. PESTEL Analysis
  • 4.12. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Oncology Spending
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Development of Novel Products
    • 5.2.2. Regulatory Imposition
    • 5.2.3. Increasing Spending on Targeted Therapies
    • 5.2.4. Increasing Prevalence of Cancer
    • 5.2.5. Strategic Mergers and Acquisitions among Local Players
    • 5.2.6. Rising Awareness towards Development of Disease
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2021 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Region

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2024 and Forecast, 2025-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2024 and Forecast 2025-2032, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2025-2032
    • 8.3.1. F-18
      • 8.3.1.1. Florbetapir
      • 8.3.1.2. Florbetaben
      • 8.3.1.3. Flutemetamol
      • 8.3.1.4. Fludeoxyglucose
      • 8.3.1.5. Sodium Fluoride
      • 8.3.1.6. Others
    • 8.3.2. C-11
      • 8.3.2.1. Choline
      • 8.3.2.2. Methionine
      • 8.3.2.3. Others
    • 8.3.3. Ga-68
      • 8.3.3.1. DOTA-TOC
      • 8.3.3.2. DOTATATE
      • 8.3.3.3. DOTANOC
      • 8.3.3.4. Others
    • 8.3.4. O-15
    • 8.3.5. N-13
    • 8.3.6. Cu-64
  • 8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2019-2024 and Forecast 2025-2032, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2025-2032
    • 9.3.1. Neurological Disorders
      • 9.3.1.1. Alzheimer's Disease
      • 9.3.1.2. Dementia
      • 9.3.1.3. Others
    • 9.3.2. Cancer Diagnosis & Prognosis
      • 9.3.2.1. Solid Tumor
      • 9.3.2.2. Hematology Tumor
    • 9.3.3. Cardiac Dysfunctions
      • 9.3.3.1. Myocardial Infarction
      • 9.3.3.2. Others
    • 9.3.4. Infectious disease Diagnosis
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis By End User

10. Global Market Analysis 2019-2024 and Forecast 2025-2032, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
    • 10.3.1. Hospitals
    • 10.3.2. Speciality Diagnostic Centers
    • 10.3.3. Cancer Research Centers
    • 10.3.4. Academic & Research Institutes
  • 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2019-2024 and Forecast 2025-2032, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2024
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2025-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. East Asia
    • 11.3.4. South Asia & Pacific
    • 11.3.5. Western Europe
    • 11.3.6. Eastern Europe
    • 11.3.7. Central Asia
    • 11.3.8. Russia & Belarus
    • 11.3.9. Balkan & Baltic Countries
    • 11.3.10. Middle East & Africa
  • 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019-2024 and Forecast 2025-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By End User
  • 12.5. Key Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Application
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Application
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2024 and Forecast 2025-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Argentina
      • 13.3.1.3. Mexico
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Key Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Brazil Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
        • 13.8.1.2.3. By End User
    • 13.8.2. Argentina Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application
        • 13.8.2.2.3. By End User
    • 13.8.3. Mexico Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Application
        • 13.8.3.2.3. By End User

14. East Asia Market Analysis 2019-2024 and Forecast 2025-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Key Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By End User
    • 14.8.2. Japan Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By End User
    • 14.8.3. South Korea Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By End User

15. South Asia & Pacific Market Analysis 2019-2024 and Forecast 2025-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Thailand
      • 15.3.1.4. Philippines
      • 15.3.1.5. Malaysia
      • 15.3.1.6. Vietnam
      • 15.3.1.7. Rest of ASEAN
      • 15.3.1.8. Australia & New Zealand
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Key Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By End User
    • 15.8.2. Indonesia Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By End User
    • 15.8.3. Thailand Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By End User
    • 15.8.4. Philippines Market
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Application
        • 15.8.4.2.3. By End User
    • 15.8.5. Malaysia Market
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Application
        • 15.8.5.2.3. By End User
    • 15.8.6. Vietnam Market
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Application
        • 15.8.6.2.3. By End User
    • 15.8.7. Australia & New Zealand Market
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Application
        • 15.8.7.2.3. By End User

16. Western Europe Market Analysis 2019-2024 and Forecast 2025-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. France
      • 16.3.1.3. Spain
      • 16.3.1.4. Italy
      • 16.3.1.5. BENELUX
      • 16.3.1.6. Nordic Countries
      • 16.3.1.7. United Kingdom
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Key Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By End User
    • 16.8.2. France Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By End User
    • 16.8.3. Spain Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application
        • 16.8.3.2.3. By End User
    • 16.8.4. Italy Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Application
        • 16.8.4.2.3. By End User
    • 16.8.5. BENULUX Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Application
        • 16.8.5.2.3. By End User
    • 16.8.6. Nordic Countries Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Application
        • 16.8.6.2.3. By End User
    • 16.8.7. U.K. Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Application
        • 16.8.7.2.3. By End User

17. Eastern Europe Market Analysis 2019-2024 and Forecast 2025-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. Poland
      • 17.3.1.2. Hungary
      • 17.3.1.3. Romania
      • 17.3.1.4. Czech Republic
      • 17.3.1.5. Rest of Eastern Europe
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Key Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Poland Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By End User
    • 17.8.2. Hungary Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By End User
    • 17.8.3. Romania Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Application
        • 17.8.3.2.3. By End User
    • 17.8.4. Czech Republic Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Application
        • 17.8.4.2.3. By End User

18. Central Asia Market Analysis 2019-2024 and Forecast 2025-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 18.3.1. By Product
    • 18.3.2. By Application
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Application
    • 18.4.3. By End User
  • 18.5. Key Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping

19. Russia & Belarus Market Analysis 2019-2024 and Forecast 2025-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 19.3.1. By Product
    • 19.3.2. By Application
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Product
    • 19.4.2. By Application
    • 19.4.3. By End User
  • 19.5. Key Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping

20. Balkan & Baltic Countries Asia Market Analysis 2019-2024 and Forecast 2025-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 20.3.1. By Product
    • 20.3.2. By Application
    • 20.3.3. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Product
    • 20.4.2. By Application
    • 20.4.3. By End User
  • 20.5. Key Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Players - Intensity Mapping

21. Middle East and Africa (MEA) Market Analysis 2019-2024 and Forecast 2025-2032

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 21.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Kingdom of Saudi Arabia
      • 21.3.1.3. Turkiye
      • 21.3.1.4. Northern Africa
      • 21.3.1.5. South Africa
      • 21.3.1.6. Israel
    • 21.3.2. By Product
    • 21.3.3. By Application
    • 21.3.4. By End User
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Product
    • 21.4.3. By Application
    • 21.4.4. By End User
  • 21.5. Key Market Trends
  • 21.6. Drivers and Restraints - Impact Analysis
  • 21.7. Key Players - Intensity Mapping
  • 21.8. Country Level Analysis & Forecast
    • 21.8.1. GCC Countries Market
      • 21.8.1.1. Introduction
      • 21.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.1.2.1. By Product
        • 21.8.1.2.2. By Application
        • 21.8.1.2.3. By End User
    • 21.8.2. Kingdom of Saudi Arabia Market
      • 21.8.2.1. Introduction
      • 21.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.2.2.1. By Product
        • 21.8.2.2.2. By Application
        • 21.8.2.2.3. By End User
    • 21.8.3. Turkiye Market
      • 21.8.3.1. Introduction
      • 21.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.3.2.1. By Product
        • 21.8.3.2.2. By Application
        • 21.8.3.2.3. By End User
    • 21.8.4. Northern Africa Market
      • 21.8.4.1. Introduction
      • 21.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.4.2.1. By Product
        • 21.8.4.2.2. By Application
        • 21.8.4.2.3. By End User
    • 21.8.5. South Africa Market
      • 21.8.5.1. Introduction
      • 21.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.5.2.1. By Product
        • 21.8.5.2.2. By Application
        • 21.8.5.2.3. By End User
    • 21.8.6. Israel Market
      • 21.8.6.1. Introduction
      • 21.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.6.2.1. By Product
        • 21.8.6.2.2. By Application
        • 21.8.6.2.3. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis
    • 22.3.1. Regional footprint of Players
    • 22.3.2. Platform Type foot print by Players
    • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Benchmarking
  • 23.3. Competition Deep Dive
    • 23.3.1. Eli Lilly and Company
      • 23.3.1.1. Company Overview
      • 23.3.1.2. Product Portfolio
      • 23.3.1.3. Sales Footprint
      • 23.3.1.4. Key Financials
      • 23.3.1.5. SWOT Analysis
      • 23.3.1.6. Key Developments
      • 23.3.1.7. Strategy Overview
        • 23.3.1.7.1. Channel Strategy
        • 23.3.1.7.2. Marketing Strategy
        • 23.3.1.7.3. Product Strategy
    • 23.3.2. Blue Earth Diagnostics
      • 23.3.2.1. Company Overview
      • 23.3.2.2. Product Portfolio
      • 23.3.2.3. Sales Footprint
      • 23.3.2.4. Key Financials
      • 23.3.2.5. SWOT Analysis
      • 23.3.2.6. Key Developments
      • 23.3.2.7. Strategy Overview
        • 23.3.2.7.1. Channel Strategy
        • 23.3.2.7.2. Marketing Strategy
        • 23.3.2.7.3. Product Strategy
    • 23.3.3. Lantheus
      • 23.3.3.1. Company Overview
      • 23.3.3.2. Product Portfolio
      • 23.3.3.3. Sales Footprint
      • 23.3.3.4. Key Financials
      • 23.3.3.5. SWOT Analysis
      • 23.3.3.6. Key Developments
      • 23.3.3.7. Strategy Overview
        • 23.3.3.7.1. Channel Strategy
        • 23.3.3.7.2. Marketing Strategy
        • 23.3.3.7.3. Product Strategy
    • 23.3.4. Siemens Healthcare Private Limited
      • 23.3.4.1. Company Overview
      • 23.3.4.2. Product Portfolio
      • 23.3.4.3. Sales Footprint
      • 23.3.4.4. Key Financials
      • 23.3.4.5. SWOT Analysis
      • 23.3.4.6. Key Developments
      • 23.3.4.7. Strategy Overview
        • 23.3.4.7.1. Channel Strategy
        • 23.3.4.7.2. Marketing Strategy
        • 23.3.4.7.3. Product Strategy
    • 23.3.5. GE Healthcare
      • 23.3.5.1. Company Overview
      • 23.3.5.2. Product Portfolio
      • 23.3.5.3. Sales Footprint
      • 23.3.5.4. Key Financials
      • 23.3.5.5. SWOT Analysis
      • 23.3.5.6. Key Developments
      • 23.3.5.7. Strategy Overview
        • 23.3.5.7.1. Channel Strategy
        • 23.3.5.7.2. Marketing Strategy
        • 23.3.5.7.3. Product Strategy
    • 23.3.6. Advanced Accelerator Applications (Novartis)
      • 23.3.6.1. Company Overview
      • 23.3.6.2. Product Portfolio
      • 23.3.6.3. Sales Footprint
      • 23.3.6.4. Key Financials
      • 23.3.6.5. SWOT Analysis
      • 23.3.6.6. Key Developments
      • 23.3.6.7. Strategy Overview
        • 23.3.6.7.1. Channel Strategy
        • 23.3.6.7.2. Marketing Strategy
        • 23.3.6.7.3. Product Strategy
    • 23.3.7. University of Lowa HealthCare
      • 23.3.7.1. Company Overview
      • 23.3.7.2. Product Portfolio
      • 23.3.7.3. Sales Footprint
      • 23.3.7.4. Key Financials
      • 23.3.7.5. SWOT Analysis
      • 23.3.7.6. Key Developments
      • 23.3.7.7. Strategy Overview
        • 23.3.7.7.1. Channel Strategy
        • 23.3.7.7.2. Marketing Strategy
        • 23.3.7.7.3. Product Strategy
    • 23.3.8. Telix Pharmaceuticals Limited
      • 23.3.8.1. Company Overview
      • 23.3.8.2. Product Portfolio
      • 23.3.8.3. Sales Footprint
      • 23.3.8.4. Key Financials
      • 23.3.8.5. SWOT Analysis
      • 23.3.8.6. Key Developments
      • 23.3.8.7. Strategy Overview
        • 23.3.8.7.1. Channel Strategy
        • 23.3.8.7.2. Marketing Strategy
        • 23.3.8.7.3. Product Strategy
    • 23.3.9. Jubilant Radiopharma
      • 23.3.9.1. Company Overview
      • 23.3.9.2. Product Portfolio
      • 23.3.9.3. Sales Footprint
      • 23.3.9.4. Key Financials
      • 23.3.9.5. SWOT Analysis
      • 23.3.9.6. Key Developments
      • 23.3.9.7. Strategy Overview
        • 23.3.9.7.1. Channel Strategy
        • 23.3.9.7.2. Marketing Strategy
        • 23.3.9.7.3. Product Strategy
    • 23.3.10. TRASIS
      • 23.3.10.1. Company Overview
      • 23.3.10.2. Product Portfolio
      • 23.3.10.3. Sales Footprint
      • 23.3.10.4. Key Financials
      • 23.3.10.5. SWOT Analysis
      • 23.3.10.6. Key Developments
      • 23.3.10.7. Strategy Overview
        • 23.3.10.7.1. Channel Strategy
        • 23.3.10.7.2. Marketing Strategy
        • 23.3.10.7.3. Product Strategy
    • 23.3.11. RadioMedix Inc.
      • 23.3.11.1. Company Overview
      • 23.3.11.2. Product Portfolio
      • 23.3.11.3. Sales Footprint
      • 23.3.11.4. Key Financials
      • 23.3.11.5. SWOT Analysis
      • 23.3.11.6. Key Developments
      • 23.3.11.7. Strategy Overview
        • 23.3.11.7.1. Channel Strategy
        • 23.3.11.7.2. Marketing Strategy
        • 23.3.11.7.3. Product Strategy
    • 23.3.12. IBA Radiopharma Solutions
      • 23.3.12.1. Company Overview
      • 23.3.12.2. Product Portfolio
      • 23.3.12.3. Sales Footprint
      • 23.3.12.4. Key Financials
      • 23.3.12.5. SWOT Analysis
      • 23.3.12.6. Key Developments
      • 23.3.12.7. Strategy Overview
        • 23.3.12.7.1. Channel Strategy
        • 23.3.12.7.2. Marketing Strategy
        • 23.3.12.7.3. Product Strategy
    • 23.3.13. Piramal Imaging (Life Molecular Imaging)
      • 23.3.13.1. Company Overview
      • 23.3.13.2. Product Portfolio
      • 23.3.13.3. Sales Footprint
      • 23.3.13.4. Key Financials
      • 23.3.13.5. SWOT Analysis
      • 23.3.13.6. Key Developments
      • 23.3.13.7. Strategy Overview
        • 23.3.13.7.1. Channel Strategy
        • 23.3.13.7.2. Marketing Strategy
        • 23.3.13.7.3. Product Strategy
    • 23.3.14. Cardinal Health
      • 23.3.14.1. Company Overview
      • 23.3.14.2. Product Portfolio
      • 23.3.14.3. Sales Footprint
      • 23.3.14.4. Key Financials
      • 23.3.14.5. SWOT Analysis
      • 23.3.14.6. Key Developments
      • 23.3.14.7. Strategy Overview
        • 23.3.14.7.1. Channel Strategy
        • 23.3.14.7.2. Marketing Strategy
        • 23.3.14.7.3. Product Strategy
    • 23.3.15. DuchemBio, Co., Ltd
      • 23.3.15.1. Company Overview
      • 23.3.15.2. Product Portfolio
      • 23.3.15.3. Sales Footprint
      • 23.3.15.4. Key Financials
      • 23.3.15.5. SWOT Analysis
      • 23.3.15.6. Key Developments
      • 23.3.15.7. Strategy Overview
        • 23.3.15.7.1. Channel Strategy
        • 23.3.15.7.2. Marketing Strategy
        • 23.3.15.7.3. Product Strategy

24. Assumptions and Acronyms Used

25. Research Methodology